Codexis Q4 Earnings Call Highlights [Yahoo! Finance]
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: Yahoo! Finance
synthesizing 10 grams of a commercially relevant siRNA, operating at 100-gram scale in its lab with a target of 0.5-kg scale by year-end, and adding stereochemical control capabilities. Commercial momentum includes a pipeline of 55 opportunities across 40 companies , a low seven-figure contract to supply 50 grams of ECO-produced siRNA for preclinical work, three CDMO agreements (Bachem, Nitto Denko Avecia, Axolabs), and planned licensing deals following the Merck technology-transfer that provided $38 million in non-dilutive capital. Q4 revenue rose to $38.9 million (FY $70.4M ) driven by the Merck deal, product gross margins improved to and the net loss narrowed to $44.0 million for 2025; the company ended the year with $78.2 million in cash, guided 2026 revenue of $72–76 million , and plans to begin retrofitting a GMP plant in H2 2026 to be operational by end-2027. Interested in Codexis, Inc.? Here are five stocks we like better. Codexis (NASDAQ:CDXS) used its fourth-quarter
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- Codexis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform [Seeking Alpha]Seeking Alpha
- Codexis (CDXS) was given a new $5.00 price target by Stifel Nicolaus.MarketBeat
- Codexis (CDXS) had its "overweight" rating reaffirmed by Cantor Fitzgerald.MarketBeat
CDXS
Earnings
- 3/11/26 - Beat
CDXS
Analyst Actions
- 3/12/26 - Cantor Fitzgerald
CDXS
Sec Filings
- 3/11/26 - Form 10-K
- 3/11/26 - Form 8-K
- 3/11/26 - Form SCHEDULE
- CDXS's page on the SEC website